Business · 16/05/2016Updated: 10/17/2026 · 1 min read
FDA Publishes Guidance on Postmarket Surveillance Under Section 522 of the FD&C Act
Summary
The FDA has released a guidance document to help device manufacturers comply with postmarket surveillance orders under Section 522 of the Federal Food, Drug, and Cosmetic Act, outlining the requirements and procedures for submitting postmarket surveillance plans.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →